Access this stock data via API
Subscribe
Takeda Pharmaceutical Company Limited
0
0
0%

Analysis

Revenue estimate Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Mar 2026)
Next year
(Mar 2027)
Number of Analysts 5 5 11 15
Avg. estimate 1.20T 1.08T 4.51T 4.53T
Low estimate 1.16T 1.03T 4.45T 4.38T
High estimate 1.26T 1.14T 4.58T 4.65T
Last year sales 1.14T 1.05T 580.36B 4.51T
Sales growth 0.05 0.02 6.77 0.01
Access /revenue_estimate data via our API — starting from the Ultra plan.
EPS revisions Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Mar 2026)
Next year
(Mar 2027)
Up last 7 days 0 0 0 0
Up last 30 days 0 0 0 0
Down last 7 days 0 0 0 0
Down last 30 days 0 0 0 0
Access /eps_revisions data via our API — starting from the Ultra plan.

Analyst ratings

Firm Date Action
TD Cowen May 16, 2023 Maintains
TD Cowen Apr 04, 2023 Maintains
B of A Securities Mar 16, 2023 Upgrade
Cowen & Co. Jul 19, 2022 Upgrade
Morgan Stanley Oct 07, 2021 Downgrade
JP Morgan Mar 11, 2020 Maintains
Cowen & Co. Nov 01, 2019 Initiates
Jefferies Sep 24, 2019 Initiates
Access /analyst_ratings/light data via our API — starting from the Ultra plan.
Market closed

Exchange is currently closed
Pre-market opens in 5 hours 16 minutes

02:43
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).